Location History:
- Apex, NC (US) (2006 - 2016)
- Hoover, AL (US) (2020)
Company Filing History:
Years Active: 2006-2020
Title: Innovations by Jon O Rayner in Alphavirus Research
Introduction
Jon O Rayner, an accomplished inventor based in Apex, NC, has made significant contributions to the field of virology with six patents to his name. His work focuses on TC-83-derived alphavirus vectors, which aim to improve vaccine efficacy and immune response.
Latest Patents
Among his latest innovations, Jon has developed patents related to TC-83 VEE-derived replicons and alphaviral replicon particles. These novel technologies include immunogenic compositions that direct the expression of at least one antigen when introduced into suitable host cells. One critical aspect of his patented TC-83 VEE-derived ARPs is their improved capability to elicit a lower vector-specific immune response compared to prior art ARPs. This advancement holds great potential for vaccine development and therapeutic applications.
Career Highlights
Jon O Rayner’s career is marked by his work with Alphavax, Incorporated, where he plays a pivotal role in advancing research and innovation in alphavirus technologies. His expertise in the field not only showcases his dedication but also his commitment to developing safer and more effective viral vectors for scientific and medical use.
Collaborations
Throughout his professional journey, Jon has collaborated with esteemed colleagues such as Jonathan F Smith and Bolyn Hubby. Together, they foster an environment of innovation and creativity, driving forward advancements in their area of research.
Conclusion
Jon O Rayner stands out as a notable inventor in the field of alphavirus research, with his groundbreaking patents paving the way for future innovations. His contributions not only enhance scientific understanding but also promote the development of improved medical therapies, demonstrating the importance of innovation in the biomedical field.